Gregg Williams Purchases 44,400 Shares of Vivani Medical, Inc. (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 44,400 shares of Vivani Medical stock in a transaction dated Monday, April 7th. The stock was purchased at an average price of $0.99 per share, with a total value of $43,956.00. Following the completion of the purchase, the director now directly owns 4,799,200 shares of the company’s stock, valued at $4,751,208. The trade was a 0.93 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Gregg Williams also recently made the following trade(s):

• On Friday, April 4th, Gregg Williams bought 34,000 shares of Vivani Medical stock. The shares were bought at an average price of $0.99 per share, with a total value of $33,660.00.
• On Wednesday, April 2nd, Gregg Williams acquired 2,000 shares of Vivani Medical stock. The stock was acquired at an average price of $1.01 per share, with a total value of $2,020.00.

Vivani Medical Price Performance

Shares of NASDAQ:VANI opened at $1.05 on Thursday. The company has a market capitalization of $62.20 million, a price-to-earnings ratio of -2.33 and a beta of 2.76. The firm’s 50 day simple moving average is $1.10 and its 200 day simple moving average is $1.20. Vivani Medical, Inc. has a fifty-two week low of $0.91 and a fifty-two week high of $2.09.

Vivani Medical (NASDAQ:VANI) last announced its earnings results on Monday, March 31st. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Equities research analysts expect that Vivani Medical, Inc. will post -0.41 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $4.00 target price on shares of Vivani Medical in a report on Friday, April 4th.

Hedge Funds Weigh In On Vivani Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC acquired a new stake in shares of Vivani Medical during the fourth quarter worth $66,000. Wealthedge Investment Advisors LLC bought a new position in Vivani Medical in the fourth quarter valued at about $43,000. Geode Capital Management LLC grew its position in Vivani Medical by 4.6% in the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock valued at $401,000 after acquiring an additional 15,008 shares during the last quarter. Finally, Northern Trust Corp grew its position in Vivani Medical by 19.1% in the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after acquiring an additional 11,540 shares during the last quarter. 6.78% of the stock is owned by institutional investors.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.